Successful determination of imatinib re-administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction.
| Autor: | Nakahara R; Department of Clinical Pharmacy Oita University Hospital Oita Japan., Sumimoto T; Department of Clinical Pharmacy Oita University Hospital Oita Japan., Tanaka R; Department of Clinical Pharmacy Oita University Hospital Oita Japan., Ogata M; Department of Hematology Oita University Hospital Oita Japan., Itoh H; Department of Clinical Pharmacy Oita University Hospital Oita Japan. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Clinical case reports [Clin Case Rep] 2021 Aug 16; Vol. 9 (8), pp. e04357. Date of Electronic Publication: 2021 Aug 16 (Print Publication: 2021). |
| DOI: | 10.1002/ccr3.4357 |
| Abstrakt: | Fixed dose regimen is currently the standard administration method for TKI. However, this case report indicated that TDM may by a useful approach to individualized dosing of TKI for the treatment of CML when initiating dialysis. Competing Interests: There are no conflicts of interest to report. (© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|